AUTOIMMUNE ENCEPHALITIS
Clinical trials for AUTOIMMUNE ENCEPHALITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE ENCEPHALITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Healthy volunteers help test safety of experimental drug ART5803
Knowledge-focused CompletedThis early-stage study looked at whether a new drug called ART5803 is safe when given together with a common immune treatment (IVIG) in 7 healthy adults. The goal was to check for side effects and how the drug moves through the body. No one in the study had the disease the drug i…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 02:53 UTC
-
Rare brain disease leaves lasting social scars, study finds
Knowledge-focused CompletedThis study looked at 20 adults who had NMDA receptor encephalitis, a rare brain disease, to understand its long-term effects on their social and emotional well-being. Researchers used questionnaires to measure memory, mood, sleep, and quality of life after the acute phase. The go…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
First step for new brain inflammation drug: is it safe?
Knowledge-focused CompletedThis early-stage study tested a new drug called ART5803 in 64 healthy adults to see if it is safe and how the body processes it. The drug is being developed for autoimmune encephalitis, a condition where the immune system attacks the brain. Since this was a Phase 1 trial, partici…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC